163 related articles for article (PubMed ID: 31266785)
21. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420
[TBL] [Abstract][Full Text] [Related]
22. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.
Whitman E; Barber A
Mol Immunol; 2015 Feb; 63(2):268-78. PubMed ID: 25089028
[TBL] [Abstract][Full Text] [Related]
23. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
24. Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy.
Kelderman S; Heemskerk B; Fanchi L; Philips D; Toebes M; Kvistborg P; van Buuren MM; van Rooij N; Michels S; Germeroth L; Haanen JB; Schumacher NM
Eur J Immunol; 2016 Jun; 46(6):1351-60. PubMed ID: 27005018
[TBL] [Abstract][Full Text] [Related]
25. Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease.
Rovati L; Kaneko N; Pedica F; Monno A; Maehara T; Perugino C; Lanzillotta M; Pecetta S; Stone JH; Doglioni C; Manfredi AA; Pillai S; Della-Torre E
Rheumatology (Oxford); 2021 Oct; 60(10):4929-4941. PubMed ID: 33512463
[TBL] [Abstract][Full Text] [Related]
26. Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors.
Kong D; Tian Q; Chen Z; Zheng H; Stashko MA; Yan D; Earp HS; Frye SV; DeRyckere D; Kireev D; Graham DK; Wang X
J Med Chem; 2024 Apr; 67(7):5866-5882. PubMed ID: 38556760
[TBL] [Abstract][Full Text] [Related]
27. CD46 is a potent co-stimulatory receptor for expansion of human IFN-γ-producing CD8
Hansen AS; Slater J; Biltoft M; Bundgaard BB; Møller BK; Höllsberg P
Immunol Lett; 2018 Aug; 200():26-32. PubMed ID: 29902483
[TBL] [Abstract][Full Text] [Related]
28. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
[TBL] [Abstract][Full Text] [Related]
29. Cell-intrinsic regulation of murine epidermal Langerhans cells by protein S.
Tabib Y; Jaber NS; Nassar M; Capucha T; Mizraji G; Nir T; Koren N; Aizenbud I; Maimon A; Eli-Berchoer L; Wilensky A; Burstyn-Cohen T; Hovav AH
Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5736-E5745. PubMed ID: 29871951
[TBL] [Abstract][Full Text] [Related]
30. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
Reiser J; Banerjee A
J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
[TBL] [Abstract][Full Text] [Related]
31. TAM Receptor Inhibition-Implications for Cancer and the Immune System.
Aehnlich P; Powell RM; Peeters MJW; Rahbech A; Thor Straten P
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801886
[TBL] [Abstract][Full Text] [Related]
32. Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
Valmori D; Dutoit V; Liénard D; Lejeune F; Speiser D; Rimoldi D; Cerundolo V; Dietrich PY; Cerottini JC; Romero P
J Immunol; 2000 Jul; 165(1):533-8. PubMed ID: 10861093
[TBL] [Abstract][Full Text] [Related]
33. MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.
Lee-Sherick AB; Jacobsen KM; Henry CJ; Huey MG; Parker RE; Page LS; Hill AA; Wang X; Frye SV; Earp HS; Jordan CT; DeRyckere D; Graham DK
JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385715
[TBL] [Abstract][Full Text] [Related]
34. CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell.
Roszkowski JJ; Yu DC; Rubinstein MP; McKee MD; Cole DJ; Nishimura MI
J Immunol; 2003 Mar; 170(5):2582-9. PubMed ID: 12594285
[TBL] [Abstract][Full Text] [Related]
35. High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.
Morgan RA; Dudley ME; Yu YY; Zheng Z; Robbins PF; Theoret MR; Wunderlich JR; Hughes MS; Restifo NP; Rosenberg SA
J Immunol; 2003 Sep; 171(6):3287-95. PubMed ID: 12960359
[TBL] [Abstract][Full Text] [Related]
36. Viral FLIP impairs survival of activated T cells and generation of CD8+ T cell memory.
Wu Z; Roberts M; Porter M; Walker F; Wherry EJ; Kelly J; Gadina M; Silva EM; DosReis GA; Lopes MF; O'Shea J; Leonard WJ; Ahmed R; Siegel RM
J Immunol; 2004 May; 172(10):6313-23. PubMed ID: 15128821
[TBL] [Abstract][Full Text] [Related]
37. Targeting MerTK Enhances Adaptive Immune Responses After Radiation Therapy.
Tormoen GW; Blair TC; Bambina S; Kramer G; Baird J; Rahmani R; Holland JM; McCarty OJT; Baine MJ; Verma V; Nabavizadeh N; Gough MJ; Crittenden M
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):93-103. PubMed ID: 32311417
[TBL] [Abstract][Full Text] [Related]
38. Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8
Powell RM; Peeters MJW; Rahbech A; Aehnlich P; Seremet T; Thor Straten P
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835225
[TBL] [Abstract][Full Text] [Related]
39. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.
Liu S; Etto T; Rodríguez-Cruz T; Li Y; Wu C; Fulbright OJ; Hwu P; Radvanyi L; Lizée G
J Immunother; 2010 May; 33(4):371-81. PubMed ID: 20386469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
